Wegovy Pill Crosses Two Million Scripts in Sixteen Weeks as Foundayo Holds at 7,335
Novo's oral GLP-1 is now a population-health event at $149 a month, while Lilly's launch trails the same week's revenue model by twenty-fourfold.
Nora Whitfield
Bureau: Chicago
Pfizer Holds Zero Buybacks for the Year as Padcev Beats Consensus by Ten Percent
Padcev cleared $591 million in the first quarter while Pfizer ruled out share repurchases for all of 2026 — a rare oncology bright spot inside an unusually disciplined balance sheet.
Utah Measles Cases Reach 638 With FLDS Communities Below Eighty Percent MMR Coverage as PAHO November Review Approaches
Utah's outbreak hits 638 cases — 441 this year — and the chain runs from RFK Jr.'s 2025 CDC autism-page change through confidence damage to FLDS-community uptake below 80 percent.
Two Big GLP-1 Studies Reach Opposite Conclusions on Mental Health
A 95,490-adult Swedish cohort shows semaglutide cuts new psychiatric illness odds by roughly 40 percent — and a same-month comparator-class study found the opposite against other diabetes drugs.
Wastewater Surveillance Watches a Third U.S. Metro for Measles as PAHO's Deadline Closes
Newark and Atlanta wastewater have flagged measles RNA for two consecutive weeks; a third metro is now on the watch list as PAHO's November elimination review approaches.
Foundayo Week Four Hits 7,335 Prescriptions, Twenty-Four Times Below the Bar Analysts Set
Lilly's oral GLP-1 wrote 7,335 scripts in its fourth week — 31 percent growth on the week, but still 24 times short of the 90,000 weekly bar RBC set for week 12.
ER Visits for Tick Bites Hit a Nine-Year April High as CDC Projects 500,000 Lyme Cases
April emergency-room tick-bite visits ran at 96 per 100,000 — the highest April rate since 2017 — and CDC now projects more than half a million Lyme diagnoses for 2026.
Tequila Distributors Print Flat Margarita Volume as the Cinco de Mayo Cycle Ends
Day five out from the holiday: distributor sell-through ran flat to slightly down against 2025, and the durable artifact is the Jose Cuervo cultural-cycle print, not the bar tab.